Veeva Systems比2026年Q4中的收入估计数高,提出了2027年的指导,并宣布收购和回购。 Veeva Systems beat earnings estimates in Q4 2026, raised 2027 guidance, and announced acquisitions and a buyback.

Veeva Systems报告收入强劲的Q4 2026,收入为2.06 EPS和8.36亿美元,两者均超过预期,其驱动因素是年比增长16%。 Veeva Systems reported strong Q4 2026 earnings, with $2.06 EPS and $836 million in revenue, both exceeding expectations, driven by 16% year-over-year growth. 该公司将2027财政年度的指导意见提高到8.85-9.00美元的EPS和1 2027至2.13-2.14美元的QPS,理由是研发和安全现代化方面的需求。 The company raised FY 2027 guidance to $8.85–$9.00 EPS and Q1 2027 to $2.13–$2.14 EPS, citing demand in R&D and safety modernization. Veeva以1亿美元购买了AI驱动的Ostro, 以促进制药业参与, Veeva acquired AI-driven Ostro for $100 million to boost pharma engagement, secured a major win with AOP Health, and announced a $5.5% share buyback. 股票交易186.96美元,市场上限为307.3亿美元。 Stock trades at $186.96 with a $30.73 billion market cap.